A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT07217015 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07217015
- Sponsor
- Kymera Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-24
- Primary completion
- 2027-06-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.